marketcaparena
Search

    PEN

    Penumbra Inc

    Company overview

    Market capitalization
    $12.57B
    Employees
    4,700
    Latest publication
    2026-09-29
    About Penumbra Inc

    Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue390,046,000USD374,758,000USD385,385,000USD354,685,000USD339,455,000USD324,140,000USD315,518,000USD301,039,000USD
    Cost Of Revenue125,102,000USD121,347,000USD123,257,000USD114,269,000USD115,445,000USD108,257,000USD104,797,000USD100,733,000USD
    Gross Profit264,944,000USD253,411,000USD262,128,000USD240,416,000USD224,010,000USD215,883,000USD210,721,000USD200,306,000USD
    Research Development25,396,000USD22,382,000USD21,794,000USD22,677,000USD23,218,000USD22,077,000USD20,010,000USD25,205,000USD
    Selling General Administrative198,509,000USD192,795,000USD181,101,000USD168,901,000USD159,964,000USD153,456,000USD147,936,000USD139,737,000USD
    Total Operating Expenses223,905,000USD215,177,000USD202,895,000USD191,578,000USD183,182,000USD175,533,000USD167,946,000USD164,942,000USD
    Operating Income41,039,000USD38,234,000USD59,233,000USD48,838,000USD40,828,000USD40,350,000USD42,775,000USD35,364,000USD
    Total Other Income Expense Net5,148,000USD3,454,000USD4,399,000USD3,487,000USD4,482,000USD3,508,000USD1,564,000USD4,414,000USD
    Interest Income5,915,000USD4,871,000USD4,560,000USD4,360,000USD3,989,000USD3,385,000USD3,276,000USD3,465,000USD
    Interest Expense311,000USD317,000USD333,000USD338,000USD319,000USD322,000USD337,000USD336,000USD
    Income Before Tax46,187,000USD41,688,000USD63,632,000USD52,325,000USD45,310,000USD43,858,000USD44,339,000USD39,778,000USD
    Income Tax Expense11,376,000USD9,104,000USD16,289,000USD6,474,000USD40,000USD4,635,000USD10,656,000USD10,251,000USD
    Net Income34,811,000USD32,584,000USD47,343,000USD45,851,000USD45,270,000USD39,223,000USD33,683,000USD29,527,000USD
    Net Interest Income—4,554,000USD4,227,000USD4,022,000USD3,670,000USD3,063,000USD2,939,000USD3,129,000USD
    Tax Provision—9,104,000USD16,289,000USD6,474,000USD40,000USD4,635,000USD10,656,000USD10,251,000USD
    Net Income From Continuing Ops—32,584,000USD47,343,000USD45,851,000USD45,270,000USD39,223,000USD33,683,000USD29,527,000USD
    Ebit—42,005,000USD63,632,000USD52,663,000USD45,629,000USD44,180,000USD44,676,000USD40,114,000USD
    Ebitda—46,579,000USD68,093,000USD55,151,000USD51,136,000USD49,195,000USD49,064,000USD44,262,000USD
    Depreciation And Amortization—4,574,000USD4,461,000USD2,488,000USD5,507,000USD5,015,000USD4,388,000USD4,148,000USD
    Reconciled Depreciation—4,574,000USD4,461,000USD2,488,000USD5,507,000USD5,015,000USD4,388,000USD4,148,000USD
    Net Income Applicable To Common Shares——47,343,000USD45,851,000USD45,270,000USD39,223,000USD33,683,000USD29,527,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20182018-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USD
    Total Revenue1,403,665,000USD1,194,615,000USD1,058,522,000USD847,133,000USD444,938,000USD263,317,000USD186,095,000USD125,510,000USD
    Cost Of Revenue461,228,000USD439,620,000USD375,879,000USD311,926,000USD152,405,000USD92,488,000USD62,037,000USD42,668,000USD
    Gross Profit942,437,000USD754,995,000USD682,643,000USD535,207,000USD292,533,000USD170,829,000USD124,058,000USD82,842,000USD
    Research Development89,766,000USD94,783,000USD84,423,000USD79,407,000USD36,165,000USD23,875,000USD18,027,000USD15,575,000USD
    Selling General Administrative663,422,000USD572,388,000USD505,254,000USD448,618,000USD226,385,000USD148,304,000USD101,852,000USD63,958,000USD
    Total Operating Expenses753,188,000USD745,716,000USD609,092,000USD529,125,000USD293,385,000USD172,179,000USD119,879,000USD79,833,000USD
    Operating Income189,249,000USD9,279,000USD73,551,000USD6,082,000USD-852,000USD-1,350,000USD4,179,000USD3,009,000USD
    Interest Income16,294,000USD13,690,000USD6,825,000USD137,000USD2,964,000USD2,323,000USD541,000USD—
    Interest Expense1,311,000USD1,418,000USD1,739,000USD1,749,000USD0USD0USD541,000USD0USD
    Net Interest Income14,983,000USD12,272,000USD5,086,000USD137,000USD2,964,000USD2,323,000USD——
    Income Before Tax205,125,000USD20,869,000USD79,650,000USD3,892,000USD1,608,000USD-869,000USD4,024,000USD3,139,000USD
    Income Tax Expense27,438,000USD6,857,000USD-11,304,000USD5,894,000USD-4,403,000USD-15,683,000USD1,659,000USD894,000USD
    Tax Provision27,438,000USD6,857,000USD-11,304,000USD5,894,000USD-4,478,000USD-15,683,000USD1,659,000USD—
    Net Income177,687,000USD14,012,000USD90,954,000USD-2,002,000USD6,601,000USD14,814,000USD2,365,000USD2,245,000USD
    Net Income From Continuing Ops177,687,000USD14,012,000USD90,954,000USD-2,002,000USD2,910,000USD14,814,000USD2,365,000USD2,245,000USD
    Ebit205,125,000USD22,287,000USD81,389,000USD5,641,000USD29,983,000USD-1,350,000USD4,179,000USD3,009,000USD
    Ebitda222,596,000USD45,989,000USD108,646,000USD29,962,000USD36,151,000USD947,000USD5,931,000USD3,760,000USD
    Depreciation And Amortization17,471,000USD23,702,000USD27,257,000USD24,321,000USD6,168,000USD2,297,000USD1,752,000USD751,000USD
    Reconciled Depreciation17,471,000USD23,702,000USD27,257,000USD24,321,000USD6,168,000USD———
    Total Other Income Expense Net15,876,000USD11,590,000USD6,099,000USD-2,190,000USD2,460,000USD-1,842,000USD-696,000USD130,000USD
    Net Income Applicable To Common Shares177,687,000USD14,012,000USD90,954,000USD-2,002,000USD6,601,000USD14,814,000USD1,084,000USD2,245,000USD
    Selling And Marketing Expenses—1,600,000USD1,200,000USD1,100,000USD500,000USD500,000USD500,000USD300,000USD
    Unclassified Operating Expenses—76,945,000USD18,215,000USD—30,335,000USD———
    Minority Interest——0USD0USD175,000USD175,000USD175,000USD—
    Non Operating Income Net Other———-2,327,000USD-3,605,000USD-1,842,000USD-696,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,974,723,000USD1,898,438,000USD1,826,519,000USD1,744,369,000USD1,674,809,000USD1,593,307,000USD1,533,181,000USD1,479,123,000USD
    Cash And Equivalents205,271,000USD—186,897,000USD321,029,000USD421,768,000USD376,054,000USD324,404,000USD280,476,000USD
    Total Current Assets1,344,122,000USD1,275,406,000USD1,216,684,000USD1,141,520,000USD1,065,484,000USD999,709,000USD951,125,000USD891,753,000USD
    Other Current Assets52,270,000USD412,283,000USD408,217,000USD55,429,000USD37,757,000USD37,017,000USD36,589,000USD31,265,000USD
    Other Non Current Assets40,691,000USD———————
    Total Liabilities443,957,000USD———————
    Total Current Liabilities233,776,000USD211,731,000USD183,133,000USD169,603,000USD157,761,000USD158,630,000USD158,345,000USD153,185,000USD
    Other Current Liabilities172,270,000USD———————
    Other Non Current Liabilities14,249,000USD———————
    Total Stockholder Equity1,530,766,000USD1,473,812,000USD1,427,603,000USD1,358,696,000USD1,293,951,000USD1,212,882,000USD1,150,931,000USD1,104,280,000USD
    Total Equity Including Noncontrolling Interest1,530,766,000USD———————
    Net Receivables190,407,000USD183,295,000USD190,021,000USD183,430,000USD175,536,000USD167,981,000USD167,668,000USD176,051,000USD
    Inventory442,650,000USD438,539,000USD431,549,000USD432,365,000USD427,628,000USD415,863,000USD406,737,000USD393,413,000USD
    Property Plant Equipment Net313,912,000USD329,541,000USD316,995,000USD295,235,000USD286,490,000USD274,922,000USD268,446,000USD269,730,000USD
    Goodwill166,523,000USD———————
    Intangible Assets5,742,000USD5,946,000USD6,186,000USD6,368,000USD6,552,000USD6,469,000USD6,513,000USD6,920,000USD
    Accounts Payable44,728,000USD43,658,000USD34,736,000USD29,821,000USD28,121,000USD31,153,000USD31,326,000USD33,151,000USD
    Short Term Debt14,398,000USD16,530,000USD16,234,000USD15,509,000USD15,251,000USD14,802,000USD14,590,000USD14,484,000USD
    Common Stock39,000USD39,000USD39,000USD39,000USD39,000USD39,000USD38,000USD38,000USD
    Retained Earnings305,086,000USD270,275,000USD237,691,000USD190,348,000USD144,497,000USD99,227,000USD60,004,000USD26,012,000USD
    Accumulated Other Comprehensive Income1,363,000USD2,075,000USD4,348,000USD3,114,000USD3,155,000USD-3,130,000USD-5,843,000USD-963,000USD
    Total Liab—424,626,000USD398,916,000USD385,673,000USD380,858,000USD380,425,000USD382,250,000USD374,843,000USD
    Other Current Liab—151,543,000USD132,163,000USD124,273,000USD114,389,000USD112,675,000USD111,489,000USD105,550,000USD
    Capital Stock—39,000USD39,000USD39,000USD39,000USD39,000USD38,000USD38,000USD
    Good Will—166,589,000USD166,750,000USD166,748,000USD166,752,000USD166,123,000USD165,826,000USD166,355,000USD
    Cash—241,289,000USD186,897,000USD321,029,000USD421,768,000USD376,054,000USD324,404,000USD280,476,000USD
    Cash And Short Term Investments—241,289,000USD186,897,000USD470,296,000USD424,563,000USD378,848,000USD340,131,000USD291,024,000USD
    Net Debt—-25,114,000USD32,802,000USD-103,984,000USD-201,239,000USD-155,399,000USD-101,015,000USD-53,787,000USD
    Short Long Term Debt Total—216,175,000USD219,699,000USD217,045,000USD220,529,000USD220,655,000USD223,389,000USD226,689,000USD
    Short Term Investments—374,371,000USD357,919,000USD149,267,000USD2,795,000USD2,794,000USD15,727,000USD10,548,000USD
    Property Plant Equipment Gross—329,541,000USD387,708,000USD295,235,000USD286,490,000USD274,922,000USD342,942,000USD341,668,000USD
    Common Stock Shares Outstanding—39,543,780shares39,392,613shares39,302,239shares39,246,000shares39,163,000shares39,268,000shares39,178,000shares
    Non Current Assets Total—623,032,000USD609,835,000USD602,848,999USD609,325,000USD593,598,000USD582,056,000USD587,370,000USD
    Non Current Liabilities Total—212,895,000USD215,783,000USD216,070,000USD223,097,000USD221,795,000USD223,905,000USD221,658,000USD
    Non Current Liabilities Other—13,250,000USD12,318,000USD14,534,000USD17,819,000USD15,942,000USD15,106,000USD9,453,000USD
    Non Currrent Assets Other—120,956,000USD119,904,000USD40,019,999USD40,390,000USD43,729,000USD40,939,000USD38,514,000USD
    Net Working Capital—1,063,675,000USD1,033,551,000USD971,917,000USD907,723,000USD841,079,000USD792,780,000USD738,568,000USD
    Unclassified Current Assets—-374,371,000USD-357,919,000USD—————
    Unclassified Non Current Liabilities—199,645,000USD203,465,000USD201,536,000USD205,278,000USD205,853,000USD208,799,000USD212,205,000USD
    Unclassified Equity—1,201,384,000USD1,185,486,000USD1,165,156,000USD1,146,221,000USD1,116,707,000USD1,096,694,000USD1,079,155,000USD
    Other Assets——119,904,000USD134,498,000USD149,531,000USD146,084,000USD141,271,000USD144,365,000USD
    Unclassified Non Current Assets——-119,904,000USD-40,020,000USD-40,390,000USD-43,729,000USD-40,939,000USD-38,514,000USD
    Current Deferred Revenue——————940,000USD1,214,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,826,519,000USD1,533,181,000USD1,556,305,000USD1,370,886,000USD1,244,250,000USD822,983,000USD665,901,000USD515,006,000USD
    Intangible Assets6,186,000USD7,195,000USD63,156,000USD91,724,000USD90,618,000USD10,639,000USD25,407,000USD27,245,000USD
    Other Current Assets408,217,000USD36,589,000USD36,424,000USD30,279,000USD29,155,000USD18,735,000USD14,852,000USD12,200,000USD
    Total Liab398,916,000USD382,250,000USD377,361,000USD372,028,000USD290,323,000USD185,195,000USD180,288,000USD92,591,000USD
    Total Stockholder Equity1,427,603,000USD1,150,931,000USD1,178,944,000USD998,858,000USD953,927,000USD641,498,000USD485,892,000USD422,240,000USD
    Other Current Liab132,163,000USD111,489,000USD103,570,000USD97,142,000USD99,796,000USD85,795,000USD67,630,000USD57,886,000USD
    Common Stock39,000USD38,000USD39,000USD38,000USD37,000USD36,000USD35,000USD34,000USD
    Capital Stock39,000USD38,000USD39,000USD38,000USD37,000USD36,000USD35,000USD34,000USD
    Retained Earnings237,691,000USD60,004,000USD134,858,000USD43,904,000USD45,906,000USD40,622,000USD57,522,000USD9,064,000USD
    Good Will166,750,000USD165,826,000USD166,270,000USD166,046,000USD166,388,000USD8,372,000USD7,656,000USD7,813,000USD
    Other Assets119,904,000USD141,271,000USD111,038,000USD77,006,000USD78,683,000USD138,101,000USD34,251,000USD33,815,000USD
    Cash186,897,000USD324,404,000USD167,486,000USD69,858,000USD59,379,000USD69,670,000USD72,779,000USD67,850,000USD
    Cash And Equivalents186,897,000USD324,404,000USD167,486,000USD69,858,000USD59,379,000USD69,670,000USD72,779,000USD67,850,000USD
    Cash And Short Term Investments186,897,000USD340,131,000USD289,187,000USD188,030,000USD254,875,000USD264,832,000USD189,389,000USD200,889,000USD
    Total Current Assets1,216,684,000USD951,125,000USD915,402,000USD755,699,000USD681,474,000USD617,702,000USD463,134,000USD410,726,000USD
    Total Current Liabilities183,133,000USD158,345,000USD151,144,000USD144,932,000USD123,197,000USD105,932,000USD91,048,000USD66,062,000USD
    Net Debt32,802,000USD-101,015,000USD66,857,000USD165,915,000USD114,169,000USD7,607,000USD9,518,000USD-67,850,000USD
    Short Term Debt16,234,000USD14,590,000USD13,434,000USD11,953,000USD9,980,000USD6,028,000USD8,307,000USD0USD
    Short Long Term Debt Total219,699,000USD223,389,000USD234,343,000USD235,773,000USD173,548,000USD77,277,000USD82,297,000USD—
    Short Term Investments357,919,000USD15,727,000USD121,701,000USD118,172,000USD195,496,000USD195,162,000USD116,610,000USD133,039,000USD
    Net Receivables190,021,000USD167,668,000USD201,768,000USD203,384,000USD133,940,000USD114,608,000USD105,901,000USD81,896,000USD
    Inventory431,549,000USD406,737,000USD388,023,000USD334,006,000USD263,504,000USD219,527,000USD152,992,000USD115,741,000USD
    Accounts Payable34,736,000USD31,326,000USD27,155,000USD26,679,000USD13,421,000USD14,109,000USD15,111,000USD8,176,000USD
    Property Plant Equipment Net316,995,000USD267,764,000USD300,439,000USD280,411,000USD227,087,000USD127,426,000USD135,453,000USD35,407,000USD
    Property Plant Equipment Gross387,708,000USD342,942,000USD352,191,000USD290,974,000USD227,087,000USD127,426,000USD135,453,000USD35,407,000USD
    Accumulated Other Comprehensive Income4,348,000USD-5,843,000USD-3,151,000USD-8,124,000USD-2,630,000USD2,541,000USD-2,324,000USD-1,942,000USD
    Common Stock Shares Outstanding39,291,828shares39,268,000shares39,216,564shares37,841,874shares37,881,180shares35,766,892shares36,265,999shares36,086,821shares
    Non Current Assets Total609,835,000USD582,056,000USD640,903,000USD615,187,000USD562,776,000USD205,281,000USD202,767,000USD104,280,000USD
    Non Current Liabilities Total215,783,000USD223,905,000USD226,217,000USD227,096,000USD167,126,000USD79,263,000USD89,240,000USD26,529,000USD
    Non Current Liabilities Other12,318,000USD15,106,000USD5,308,000USD3,276,000USD3,558,000USD79,263,000USD11,245,000USD14,772,000USD
    Non Currrent Assets Other119,904,000USD40,939,000USD25,880,000USD12,793,000USD12,985,000USD8,705,000USD2,946,000USD875,000USD
    Net Working Capital1,033,551,000USD792,780,000USD764,258,000USD610,767,000USD558,277,000USD511,770,000USD372,086,000USD344,664,000USD
    Unclassified Current Assets-357,919,000USD———————
    Unclassified Non Current Assets-119,904,000USD-40,939,000USD-25,880,000USD-12,793,000USD-12,985,000USD-87,962,000USD-2,946,000USD—
    Unclassified Non Current Liabilities203,465,000USD208,799,000USD220,909,000USD215,444,000USD154,210,000USD-8,014,000USD62,745,000USD-22,358,000USD
    Unclassified Equity1,185,486,000USD1,096,694,000USD1,047,159,000USD963,002,000USD910,577,000USD598,263,000USD430,624,000USD415,050,000USD
    Current Deferred Revenue—940,000USD6,985,000USD9,158,000USD—82,795,000USD63,339,000USD—
    Deferred Long Term Liab———5,100,000USD5,800,000USD——7,586,000USD
    Other Liab———3,276,000USD3,558,000USD8,014,000USD15,250,000USD26,529,000USD
    Net Tangible Assets———751,651,000USD696,921,000USD622,487,000USD449,299,000USD384,387,000USD
    Unclassified Current Liabilities—————-82,795,000USD-63,339,000USD—
    Long Term Investments———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation10,189,000USD
    Stock Based Compensation28,304,000USD
    Deferred Income Tax-69,000USD
    Change To Account Receivables-2,496,000USD
    Change To Inventory-14,344,000USD
    Change To Liabilities45,110,000USD
    Change In Working Capital-7,554,000USD
    Operating Cash Flow133,055,000USD
    Capital Expenditures-27,213,000USD
    Net Investments-93,511,000USD
    Other Investing Activities1,000,000USD
    Unclassified Investing Cash Flow-2,000,000USD
    Investing Cash Flow-121,724,000USD
    Net Debt Issuance-1,235,000USD
    Common Stock Issuance9,674,000USD
    Net Common Stock Issuance-1,321,000USD
    Other Financing Activities0USD
    Financing Cash Flow7,118,000USD
    Effect Of Forex Changes On Cash-75,000USD
    Change In Cash18,374,000USD
    End Cash Flow205,271,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income32,584,000USD47,343,000USD45,851,000USD45,270,000USD39,223,000USD33,683,000USD29,527,000USD-60,200,000USD
    Depreciation4,574,000USD4,461,000USD2,488,000USD5,507,000USD5,015,000USD4,388,000USD4,147,999USD7,647,000USD
    Stock Based Compensation14,645,000USD15,262,000USD15,932,000USD14,234,000USD13,785,000USD12,095,000USD10,940,000USD9,560,000USD
    Other Non Cash Items423,000USD795,000USD1,276,000USD966,000USD2,937,000USD5,427,000USD5,465,000USD113,693,000USD
    Change To Account Receivables5,542,000USD-6,824,000USD-8,451,000USD-4,782,000USD543,000USD3,232,000USD25,394,000USD-10,489,000USD
    Change To Inventory-9,019,000USD-630,000USD-3,719,000USD-11,371,000USD-10,762,000USD2,710,000USD-23,039,000USD-11,334,000USD
    Change In Working Capital35,472,000USD3,563,000USD-22,005,000USD-14,282,000USD-9,992,000USD-9,085,000USD3,590,000USD-23,878,000USD
    Total Cash From Operating Activities86,971,000USD86,484,000USD58,263,000USD44,946,000USD48,970,000USD51,108,000USD56,467,000USD22,611,000USD
    Capital Expenditures-13,671,000USD-18,434,000USD-16,249,000USD-15,579,000USD-13,467,000USD-5,371,000USD-5,451,000USD-4,536,000USD
    Free Cash Flow73,300,000USD68,050,000USD42,014,000USD29,367,000USD35,503,000USD45,737,000USD51,016,000USD18,075,000USD
    Investments-15,962,000USD-207,213,000USD-162,861,000USD-15,580,000USD-502,000USD-10,955,000USD35,721,000USD34,474,000USD
    Total Cashflows From Investing Activities-30,633,000USD-225,647,000USD-162,861,000USD-15,580,000USD-502,000USD-10,955,000USD35,721,000USD34,474,000USD
    Net Borrowings-617,000USD-569,000USD-612,000USD-691,000USD-613,000USD-589,000USD-578,000USD—
    Total Cash From Financing Activities-1,907,000USD5,057,000USD3,950,000USD14,817,000USD2,708,000USD6,068,000USD-100,554,000USD8,273,999USD
    Sale Purchase Of Stock-1,290,000USD31,819,000USD24,244,000USD19,592,000USD4,022,000USD1,000USD-100,388,000USD-89,000USD
    Change In Cash54,392,000USD-134,132,000USD-100,739,000USD45,714,000USD51,650,000USD43,928,000USD-7,856,000USD65,218,000USD
    Begin Period Cash Flow186,897,000USD321,029,000USD421,768,000USD376,054,000USD324,404,000USD280,476,000USD288,332,000USD223,114,000USD
    End Period Cash Flow241,289,000USD186,897,000USD321,029,000USD421,768,000USD376,054,000USD324,404,000USD280,476,000USD288,332,000USD
    Other Cashflows From Investing Activities-1,000,000USD-340,861,000USD-133,648,000USD12,964,000USD12,965,000USD-500,000USD104,390,000USD-500,000USD
    Other Cashflows From Financing Activities-1,290,000USD-1,949,000USD-90,000USD-62,000USD-701,000USD-874,000USD-72,000USD-89,000USD
    Unclassified Financing Cash Flow1,290,000USD-24,244,000USD-19,592,000USD-4,022,000USD—7,530,000USD—8,451,999USD
    Unclassified Operating Cash Flow—15,060,000USD14,721,000USD-6,749,000USD-1,998,000USD4,600,000USD2,797,001USD-24,211,000USD
    Unclassified Investing Cash Flow—340,861,000USD149,897,000USD2,615,000USD—5,871,000USD-98,939,000USD5,036,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20172017-12-31 · USD
    Net Income177,687,000USD14,012,000USD90,954,000USD-2,001,999USD5,284,000USD-19,257,000USD48,458,000USD4,657,000USD
    Depreciation17,471,000USD23,702,000USD30,607,000USD27,574,000USD19,490,000USD12,891,000USD7,852,000USD3,781,000USD
    Stock Based Compensation59,213,000USD46,164,000USD50,516,000USD37,378,000USD65,763,000USD25,541,000USD21,485,000USD17,812,000USD
    Other Non Cash Items5,974,000USD124,722,000USD73,917,000USD38,844,000USD65,530,000USD17,591,000USD25,364,000USD4,218,000USD
    Change To Account Receivables-19,514,000USD26,597,000USD-266,000USD-69,857,000USD-21,344,000USD-8,295,000USD-25,029,000USD-9,118,000USD
    Change To Inventory-26,482,000USD-65,658,000USD-67,710,000USD-74,631,000USD-51,554,000USD-56,981,000USD-41,407,000USD-18,826,000USD
    Change In Working Capital-42,716,000USD-23,780,000USD-79,084,000USD-121,535,000USD-66,711,000USD-51,190,000USD-56,842,000USD-13,489,000USD
    Total Cash From Operating Activities238,663,000USD168,481,000USD97,333,000USD-55,661,000USD9,502,000USD-33,242,000USD26,652,000USD12,691,000USD
    Capital Expenditures-63,729,000USD-21,182,000USD-15,213,000USD-19,298,000USD-21,180,000USD-24,756,000USD-22,109,000USD-15,032,000USD
    Free Cash Flow174,934,000USD147,299,000USD82,120,000USD-74,959,000USD-11,678,000USD-57,998,000USD4,543,000USD-2,341,000USD
    Investments-340,861,000USD77,624,000USD-31,723,000USD74,088,000USD-3,074,000USD-76,333,000USD18,034,000USD-77,653,000USD
    Total Cashflows From Investing Activities-404,590,000USD77,624,000USD-16,076,000USD54,790,000USD-21,735,000USD-104,149,000USD-11,911,000USD-77,653,000USD
    Net Borrowings-2,485,000USD-2,276,000USD-1,981,000USD-1,751,000USD-1,451,000USD-3,418,000USD-2,570,000USD-1,079,000USD
    Total Cash From Financing Activities26,532,000USD-87,006,000USD16,203,000USD11,622,000USD836,000USD134,917,000USD-9,759,000USD104,359,000USD
    Sale Purchase Of Stock31,819,000USD-100,387,000USD-2,074,000USD-8,042,000USD-15,832,000USD-10,066,000USD-18,535,000USD-11,686,000USD
    Change In Cash-137,507,000USD156,918,000USD97,628,000USD10,479,000USD-10,291,000USD-3,109,000USD4,929,000USD37,401,000USD
    Begin Period Cash Flow324,404,000USD167,486,000USD69,858,000USD59,379,000USD69,670,000USD72,779,000USD67,850,000USD13,236,000USD
    End Period Cash Flow186,897,000USD324,404,000USD167,486,000USD69,858,000USD59,379,000USD69,670,000USD72,779,000USD50,637,000USD
    Other Cashflows From Investing Activities-340,861,000USD1,100,000USD-500,000USD74,088,000USD-400,000USD-3,060,000USD-8,636,000USD-55,868,000USD
    Other Cashflows From Financing Activities-2,802,000USD-1,517,000USD-2,229,000USD-8,179,000USD-16,082,000USD3,576,000USD-20,293,000USD-829,000USD
    Unclassified Operating Cash Flow21,034,000USD-16,339,000USD-69,577,000USD-35,920,001USD-79,854,000USD-18,818,000USD-19,665,000USD-4,288,000USD
    Unclassified Investing Cash Flow340,861,000USD20,082,000USD31,360,000USD-74,088,000USD2,919,000USD——70,900,000USD
    Unclassified Financing Cash Flow—17,174,000USD22,487,000USD37,636,000USD50,033,000USD154,891,000USD50,174,000USD117,953,000USD
    Change To Liabilities———23,927,000USD-1,565,000USD22,951,000USD-13,595,000USD1,851,000USD
    Dividends Paid———-8,042,000USD-15,832,000USD-10,066,000USD-18,535,000USD0USD
    Issuance Of Capital Stock———0USD0USD134,759,000USD134,759,000USD—
    Cash And Cash Equivalents Changes———10,751,000USD-11,397,000USD-2,474,000USD-48,322,000USD37,401,000USD
    Exchange Rate Changes———————-1,996,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyInternational84,601,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States305,445,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductEmbolization And Access131,065,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductThrombectomy258,981,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyInternational78,371,000USD0001321732-26-000019
    Q1 2026Quarterly · 2026-03-31GeographyUnited States296,387,000USD0001321732-26-000019
    Q1 2026Quarterly · 2026-03-31ProductEmbolization And Access120,841,000USD0001321732-26-000019
    Q1 2026Quarterly · 2026-03-31ProductThrombectomy253,917,000USD0001321732-26-000019
    FY 2025Yearly · 2025-12-31GeographyInternational311,904,000USD0001321732-26-000007
    FY 2025Yearly · 2025-12-31GeographyUnited States1,091,761,000USD0001321732-26-000007
    FY 2025Yearly · 2025-12-31ProductEmbolization455,747,000USD0001321732-26-000007
    FY 2025Yearly · 2025-12-31ProductThrombectomy947,918,000USD0001321732-26-000007
    Q3 2025Quarterly · 2025-09-30GeographyOther Non US79,656,000USD0001321732-25-000109
    Q3 2025Quarterly · 2025-09-30GeographyUnited States275,029,000USD0001321732-25-000109
    Q3 2025Quarterly · 2025-09-30ProductEmbolization And Access118,263,000USD0001321732-25-000109
    Q3 2025Quarterly · 2025-09-30ProductThrombectomy236,422,000USD0001321732-25-000109
    Q2 2025Quarterly · 2025-06-30GeographyOther Non US78,637,000USD0001321732-25-000098
    Q2 2025Quarterly · 2025-06-30GeographyUnited States260,818,000USD0001321732-25-000098
    Q2 2025Quarterly · 2025-06-30ProductEmbolization And Access109,199,000USD0001321732-25-000098
    Q2 2025Quarterly · 2025-06-30ProductThrombectomy230,256,000USD0001321732-25-000098
    Q1 2025Quarterly · 2025-03-31GeographyInternational67,280,000USD0001321732-26-000019
    Q1 2025Quarterly · 2025-03-31GeographyUnited States256,860,000USD0001321732-26-000019
    Q1 2025Quarterly · 2025-03-31ProductEmbolization And Access97,596,000USD0001321732-26-000019
    Q1 2025Quarterly · 2025-03-31ProductThrombectomy226,544,000USD0001321732-26-000019
    FY 2024Yearly · 2024-12-31GeographyInternational292,548,000USD0001321732-26-000007
    FY 2024Yearly · 2024-12-31GeographyUnited States902,067,000USD0001321732-26-000007
    FY 2024Yearly · 2024-12-31ProductEmbolization379,140,000USD0001321732-26-000007
    FY 2024Yearly · 2024-12-31ProductThrombectomy815,475,000USD0001321732-26-000007
    Q3 2024Quarterly · 2024-09-30GeographyOther Non US74,713,000USD0001321732-25-000109
    Q3 2024Quarterly · 2024-09-30GeographyUnited States226,326,000USD0001321732-25-000109
    Q3 2024Quarterly · 2024-09-30ProductEmbolization And Access96,898,000USD0001321732-25-000109
    Q3 2024Quarterly · 2024-09-30ProductThrombectomy204,141,000USD0001321732-25-000109
    Q2 2024Quarterly · 2024-06-30GeographyOther Non US81,223,000USD0001321732-25-000098
    Q2 2024Quarterly · 2024-06-30GeographyUnited States218,180,000USD0001321732-25-000098
    Q2 2024Quarterly · 2024-06-30ProductEmbolization And Access95,901,000USD0001321732-25-000098
    Q2 2024Quarterly · 2024-06-30ProductThrombectomy203,502,000USD0001321732-25-000098
    Q1 2024Quarterly · 2024-03-31GeographyOther Non US69,011,000USD0001321732-25-000086
    Q1 2024Quarterly · 2024-03-31GeographyUnited States209,644,000USD0001321732-25-000086
    Q1 2024Quarterly · 2024-03-31ProductEmbolization And Access90,952,000USD0001321732-25-000086
    Q1 2024Quarterly · 2024-03-31ProductThrombectomy187,703,000USD0001321732-25-000086
    FY 2023Yearly · 2023-12-31GeographyInternational301,371,000USD0001321732-26-000007
    FY 2023Yearly · 2023-12-31GeographyUnited States757,151,000USD0001321732-26-000007
    FY 2023Yearly · 2023-12-31ProductEmbolization381,179,000USD0001321732-26-000007
    FY 2023Yearly · 2023-12-31ProductThrombectomy677,343,000USD0001321732-26-000007
    FY 2022Yearly · 2022-12-31GeographyInternational255,418,000USD0001321732-25-000012
    FY 2022Yearly · 2022-12-31GeographyUnited States591,715,000USD0001321732-25-000012
    FY 2022Yearly · 2022-12-31ProductEmbolization335,996,000USD0001321732-25-000012
    FY 2022Yearly · 2022-12-31ProductThrombectomy511,137,000USD0001321732-25-000012
    FY 2021Yearly · 2021-12-31GeographyInternational219,801,000USD0001321732-24-000025
    FY 2021Yearly · 2021-12-31GeographyUnited States527,789,000USD0001321732-24-000025
    FY 2021Yearly · 2021-12-31ProductEmbolization309,815,000USD0001321732-24-000025
    FY 2021Yearly · 2021-12-31ProductThrombectomy437,775,000USD0001321732-24-000025
    FY 2020Yearly · 2020-12-31GeographyInternational160,142,000USD0001321732-23-000034
    FY 2020Yearly · 2020-12-31GeographyUnited States400,270,000USD0001321732-23-000034
    FY 2020Yearly · 2020-12-31ProductNeuro292,629,000USD0001321732-23-000034
    FY 2020Yearly · 2020-12-31ProductPeripheral Vascular267,783,000USD0001321732-23-000034
    FY 2019Yearly · 2019-12-31GeographyJapan42,520,000USD0001321732-20-000047
    FY 2019Yearly · 2019-12-31GeographyOther Non US149,663,000USD0001321732-20-000047
    FY 2019Yearly · 2019-12-31GeographyUnited States355,222,000USD0001321732-20-000047
    FY 2019Yearly · 2019-12-31ProductNeuro331,685,000USD0001321732-22-000017
    FY 2019Yearly · 2019-12-31ProductPeripheral Vascular215,720,000USD0001321732-22-000017
    FY 2018Yearly · 2018-12-31GeographyJapan41,805,000USD0001321732-20-000047
    FY 2018Yearly · 2018-12-31GeographyOther Non US112,417,000USD0001321732-20-000047
    FY 2018Yearly · 2018-12-31GeographyUnited States290,716,000USD0001321732-20-000047
    FY 2018Yearly · 2018-12-31ProductNeuro294,333,000USD0001628280-21-002867
    FY 2018Yearly · 2018-12-31ProductPeripheral Vascular150,605,000USD0001628280-21-002867

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.